Book.
0000 - Gale Group | The Making of Modern World
Oh Chan Kwon, Min‐Chan Park, Yong‐Gil Kim,
Interleukin-32 (IL-32) is an important cytokine involved in the innate and adaptive immune responses. The role of IL-32 has been studied in the context of various ... of research has investigated the role of IL-32 in rheumatic diseases including inflammatory arthritides (rheumatoid arthritis, ... granulomatosis and polyangiitis, and giant cell arteritis). IL-32 has been shown to play different roles according ... rheumatic diseases. Hence, the putative role of IL-32 as a biomarker is also different in each rheumatic disease: IL-32 could serve as a biomarker for disease activity ...
Tópico(s): Spondyloarthritis Studies and Treatments
2023 - Frontiers Media | Frontiers in Immunology
St. Bartholomew's Hospital Archives & Museum, Wellcome Images. 18.2 cm x 14.9 cm. Series: Medical Photographic Library.
0000 - Gale Group | NCCO Photography
Liping Qiu, Min Lv, Cheng Chen, Juan Li, Baihui Zhao, Qiong Luo,
... the rate of spontaneous preterm birth at <28, <32, <34, <36 weeks’ gestation, and neonatal outcomes. RESULTS ... The rates of spontaneous preterm birth at <28, <32, <34, and <36 weeks’ gestation were significantly lower ... group, gestational age at delivery was significantly higher (32.95±3.81 vs 30.24±4.01 ... 0.04; 95% confidence interval, 0.01–0.32; P=.003) and the composite adverse neonatal outcomes ( ... P=.001), rates of spontaneous preterm birth at <32 weeks (16.7% vs 54.2%; adjusted odds ... will significantly decrease the risk of delivery at <32 and <34 weeks’ gestation and prolong pregnancy latency. ...
Tópico(s): Maternal and Perinatal Health Interventions
2023 - Elsevier BV | American Journal of Obstetrics & Gynecology MFM
St. Bartholomew's Hospital Archives & Museum, Wellcome Images. 18.9 cm x 13.1 cm. Series: Medical Photographic Library.
0000 - Gale Group | NCCO Photography
Anna Vyazovaya, Alena Gerasimova, Regina Mudarisova, Daria Terentieva, Natalia Solovieva, Viacheslav Zhuravlev, Igor Mokrousov,
... The largest Central Asian/Russian types were 94-32 (n = 75), 1065-32 (n = 17), and 95-32 (n = 12). B0/W148 types were 100-32 (n = 59) and 4737-32 (n = 5). MDR was more frequent in types 1065-32 (88.2%), 100-32 (83.1%), and 4737-32 (100%). In contrast, type 9391-32 (n = 9) included only drug-susceptible strains. To ... presence of MDR-associated minor variants (type 1071-32/ancient Beijing and Central Asia Outbreak strain) in ...
Tópico(s): Infectious Diseases and Tuberculosis
2023 - Multidisciplinary Digital Publishing Institute | Microorganisms
Accounts: Ledgers, Home Ledger. 32, 1716-1717
1717 - Gale Group | SASII
Y. T. Yan, C. Henkel, Chiaki Kobayashi, K. M. Menten, Y. Gong, J. S. Zhang, Hongzhi Yu, Kai Yang, Jinjin Xie, Y. X. Wang,
... aim to measure the 12 C/ 13 C, 32 S/ 34 S, 32 S/ 33 S, 32 S/ 36 S, 34 S/ 33 S, 34 ... Results. We measured the 12 C/ 13 C, 32 S/ 34 S, 32 S/ 33 S, 32 S/ 36 S, 34 S/ 33 S, 34 ... confirm previously identified 12 C/ 13 C and 32 S/ 34 S gradients as a function of ... values as a function of galactocentric radius. While 32 S/ 34 S ratios near the Galactic center ... values. A comparison between solar and local interstellar 32 S/ 34 S and 34 S/ 33 S ... the first time, we report positive gradients of 32 S/ 33 S, 34 S/ 36 S, 33 ...
Tópico(s): Astro and Planetary Science
2023 - EDP Sciences | Astronomy and Astrophysics
Accounts: Ledgers, Home Ledger. 32, 1716-1717
1717 - Gale Group | SASII
Shichao Xie, Xiangkai Li, Yuhang Yang, Chen Guo, Xiangsheng Zhang, Tingting Zhu, Jiaxiang Luo, Yang Zheng, Wenli Zhao, Yuhui Cui, Lefei Jiao, Qicun Zhou, Douglas R. Tocher, Min Jin,
... of isoleucine being 0.69%, 1.06%, 1.32%, 1.78%, 2.03% and 2.38%, respectively. ... observed in crabs fed the diet with 1.32% isoleucine. Hepatopancreas expression levels of genes related to ... ast, were up-regulated in crabs fed 1.32% isoleucine compared to the other groups, whereas the ... glut1, were significantly higher in crabs fed 1.32% isoleucine compared to crabs fed 0.69% isoleucine. ... than in crabs fed the diets with 1.32% and 1.78% isoleucine. In contrast, expression levels ... pk, were up-regulated in crabs fed 1.32% isoleucine compared to crabs fed 0.69% isoleucine. ...
Tópico(s): Crustacean biology and ecology
2023 - Elsevier BV | Aquaculture
Register of Free Black Men, 1831-32 (1 volume). Entry 222, Box 585
1832 - Gale Group | SASII
Hirokazu Miyashita, Noriaki Moriyama, Sebastian Dahlbacka, Tommi Vähasilta, Tiina Vainikka, Mikko Jalanko, Juho Viikilä, Mika Laine,
... Helsinki University Central Hospital (n = 1,182), and 32 patients were excluded (Figure 1). The baseline characteristics, ... received MANTA for large-bore arteriotomy closure, and 32 patients were excluded from the analysis (Figure 1). ... 5%)90 (11%)0.070.1220 (6.7%)32 (11%)0.080.14Prior non-CABG77 (6.7%) ... 7%)13 (4.4%)0.450.061OAC mono373 (32%)108 (32%)265 (32%)0.930.00693 (31%)97 (32%)0.730.029 Defined as presenting LDL cholesterol ≥ ... cm361 (31%)113 (34%)248 (30%)0.2796 (32%)96 (32%)1.00MFACS0.94 ± 1.070.97 ± 1.120. ... 1%)72 (8.8%)0.6725 (8.4%)32 (11%)0.33Posterior calcification563 (49%)164 (49%)399 ( ...
Tópico(s): Venous Thromboembolism Diagnosis and Management
2022 - Elsevier BV | The American Journal of Cardiology
Project Gutenberg
Register of Free Black Women, 1831-32 (1 volume). Entry 223, Box 585
1832 - Gale Group | SASII
Jonathan I. Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew Pink, Andrea Chiricozzi, S. Barbarot, Thomas Mark, Ann-Marie Tindberg, Stephan Weidinger,
... topical corticosteroids (TCS) as needed were evaluated over 32 weeks in the phase III ECZTRA 3 trial. ... related quality of life (QoL) over the entire 32-week treatment period of ECZTRA 3, including all ... 4% (127/252) achieving EASI-90 at Week 32. Improvements in patient-reported outcomes were observed within ... plus TCS treatment and were sustained throughout the 32-week period. At Week 32, patients initiated on tralokinumab q2w plus TCS achieved ... Index (DLQI). Mean TCS use during Weeks 16–32 ranged from 9.2 to 13.6 g ( ...
Tópico(s): Allergic Rhinitis and Sensitization
2022 - Adis, Springer Healthcare | American Journal of Clinical Dermatology
Accounts: Journal and Warrant Books-Home, Journal. (32), 1716-1717
1717 - Gale Group | SASII
Mauro Scaravilli, Sonja Koivukoski, Andrew Gillen, Aya Bouazza, Pekka Ruusuvuori, Tapio Visakorpi, Leena Latonen,
miR-32 is an androgen receptor (AR)-regulated microRNA, expression of which is increased in castration-resistant prostate cancer ( ... We have previously shown that overexpression of miR-32 in the prostate of transgenic mice potentiates proliferation ... out to determine whether increased expression of miR-32 influences growth or phenotype in prostate adenocarcinoma in ... prostate and discovered that transgenic overexpression of miR-32 resulted in increased tumor burden as well as ... phenotype in this model. Elevated expression of miR-32 increased proliferation as assessed by Ki-67 immunohistochemistry, ...
Tópico(s): RNA Research and Splicing
2022 - Springer Nature | Oncogenesis
Volume 32 No 38 November 3, 1892. Memorandum. From Rosebery.
0000 - Gale Group | NCCO BritishPolitics
Matteo Marchetti, Stefano Barelli, Tobias Gleich, Francisco J. Gómez, Matthew Goodyer, Francesco Grandoni, Lorenzo Alberio,
... recommendations based on our experience. This cohort of 32 patients is the largest describing cases of HIT ... August 2021. Between August 2014 and February 2019, 32 patients with confirmed HIT14 [positive anti-PF4/heparin ... rate of death related to HIT (n = 1/32 vs. 0/16), a similar rate of thromboembolic complications (n = 13/32, 41% vs. n = 7/16, 44%), and less major bleeding (n = 4/32, 13% vs. n = 3/16, 19%) and overall death rates (n = 4/32, 13% vs. n = 4/16, 25%). Individual clinical ... 0.98 μg/kg/min (0.61–1.32), and 1.27 μg/kg/min (0.90– ...
Tópico(s): Venous Thromboembolism Diagnosis and Management
2022 - Wiley | British Journal of Haematology
Register of Free Black Men, 1831-32 (1 volume). Entry 214, Box 583
1832 - Gale Group | SASII
Milind Y. Desai, Anjali Owens, Jeffrey B. Geske, Kathy Wolski, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Aarthi Balasubramanyam, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen,
... mavacamten on the need for SRT through week 32 in oHCM.A double-blind randomized placebo-controlled ... initially randomized to mavacamten continued the drug for 32 weeks, and the placebo group crossed over to dose-blinded mavacamten from week 16 to week 32. Dose titrations were based on investigator-blinded echocardiographic ... proceeding with SRT or remaining guideline eligible at 32 weeks in both treatment groups.From the 112 ... Heart Association class III/IV) qualified for week 32 evaluation (56 in the original mavacamten group and ...
Tópico(s): Cardiovascular Effects of Exercise
2022 - Lippincott Williams & Wilkins | Circulation